[ad_1] Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) Director Louis A. Cannon bought 10,000 shares of the business’s stock in a transaction on Wednesday, March 27th. The stock was bought at an [...]
[ad_1] Corindus Vascular Robotics is part of the medical devices industry and healthcare sector. The company CEO is Mark J. Toland. Corindus Vascular Robotics Inc is engaged in the design, [...]
[ad_1] Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) Director Louis A. Cannon bought 573,798 shares of the business’s stock in a transaction dated Tuesday, March 12th. The stock was bought at an [...]
[ad_1] Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) was the target of a large growth in short interest in February. As of February 28th, there was short interest totalling 12,833,085 shares, a [...]
[ad_1] Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) Director Louis A. Cannon purchased 573,798 shares of the stock in a transaction on Tuesday, March 12th. The shares were bought at an average [...]
[ad_1] Corindus Vascular Robotics (NYSEAMERICAN:CVRS) will be releasing its earnings data after the market closes on Tuesday, March 12th. Analysts expect Corindus Vascular Robotics to post earnings of ($0.04) per [...]
[ad_1] Shares of Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) traded down 3.5% during trading on Wednesday . The stock traded as low as $1.43 and last traded at $1.38. 45,513 shares [...]
[ad_1] Analysts expect Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) to report $-0.04 EPS on March, 13.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.04 EPS. After having $-0.04 [...]
[ad_1] Corindus Vascular Robotics trades as part of the healthcare sector and medical devices industry. The company CEO is Mark J. Toland. Corindus Vascular Robotics Inc is engaged in the [...]
[ad_1] Analysts expect Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) to report $-0.04 EPS on March, 13.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.04 EPS. After having $-0.04 [...]
